Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€105.32

€105.32

-0.490%
-0.52
-0.490%
-
 
29.01.26 / Tradegate WKN: 890952 / Symbol: CMXHF / Name: CSL / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

CSL Ltd Stock

The price for the CSL Ltd stock decreased slightly today. Compared to yesterday there is a change of -€0.520 (-0.490%).

Pros and Cons of CSL Ltd in the next few years

Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of CSL Ltd vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
CSL Ltd -0.490% 1.503% 6.255% -36.301% 6.127% -45.231% -38.250%
Grifols S.A. -2.140% -0.184% -0.914% 26.724% -0.778% -13.591% -55.519%
Regeneron Pharmaceuticals Inc. -0.670% -2.613% -5.579% -5.150% -5.579% -8.397% 50.964%
Johnson & Johnson 0.050% 2.118% 7.688% 30.831% 7.469% 22.716% 41.388%

News

This Growth Stock Is Building Its Case to Smart Investors: https://g.foolcdn.com/editorial/images/852022/home-construction-getty.jpg
This Growth Stock Is Building Its Case to Smart Investors

There's a boom going on in much of the U.S., and it's not just tied to technology. Housing shortages have spurred residential homebuilding activity, particularly in fast-growing areas like the Sun

Flu Season's Here—This Dividend-Payer Controls the Shot Market: https://www.marketbeat.com/logos/articles/med_20260105104300_flu-seasons-herethis-dividend-payer-controls-the-s.png
Flu Season's Here—This Dividend-Payer Controls the Shot Market

Last year wasn’t kind to the health care sector. That corner of the market, which includes Big Pharma mainstays such as Eli Lilly (NYSE: LLY), Johnson & Johnson (NYSE: JNJ), and AbbVie (NYSE: